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Abstract
Tumor microenvironement is an important actor of ovarian cancer progression but the relations between mesenchymal
cells and ovarian cancer cells remain unclear. The objective of this study was to determine the ovarian cancer cells’
biological modifications induced by mesenchymal cells. To address this issue, we used two different ovarian cancer cell lines
(NIH:OVCAR3 and SKOV3) and co-cultured them with mesenchymal cells. Upon co-culture the different cell populations
were sorted to study their transcriptome and biological properties. Transcriptomic analysis revealed three biological-
function gene clusters were enriched upon contact with mesenchymal cells. These were related to the increase of
metastatic abilities (adhesion, migration and invasion), proliferation and chemoresistance in vitro. Therefore, contact with
the mesenchymal cell niche could increase metastatic initiation and expansion through modification of cancer cells. Taken
together these findings suggest that pathways involved in hetero-cellular interaction may be targeted to disrupt the
acquired pro-metastatic profile.
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Introduction
Most patients with ovarian cancer generally die from peritoneal
disease [1]. Development of peritoneal carcinomatosis involves
defined critical steps, including cell shedding, interaction and
adhesion to mesothelial layer, and proliferation into the sub-
mesothelium [2]. Several reports describe a pre-metastatic niche
within the target organ, facilitating the initial survival of tumor
cells [3,4,5].
Mesenchymal cells (MCs) are pluripotent cells that give rise to a
variety of connective tissue cell types [6]. Bone Marrow-derived
Mesenchymal Stem Cells (BM-MSC) are recruited in significant
number to tumor sites where they contribute to invasion,
metastasis, and resistance to chemotherapy of ovarian cancer cell
lines [7,8,9,10,11]. MSC have been shown to contribute to
ovarian cancer tumorigenicity through altered production of Bone
Morphogenetic Protein (BMP2) leading to an increase of ovarian
cancer cell (OCC) proliferation in vitro and in vivo [12]. While many
studies focus on specific factors in the acquisition of metastatic
profile, only few studies are assessing the global transcriptomic
changes occurring in cancer cells upon their interaction with the
mesenchymal stem cells (MSC) [13]. Zhang S et al.
13 reported the
modification of the prostate cancer cell transcriptome induced by
interaction with MCs. The modifications defined a new pro-
metastatic state. Understanding the pathways impacted by the
interaction of cancer cells and their microenvironment and the
induced global modifications is mandatory in order to be able to
target microenvironment specific pathways [13].
Here, we investigate co-culture of two different types of OCC
lines with MCs. We demonstrate that this interaction enhances
metastatic abilities of OCC. Using transcriptomic analysis and
functional assays; we demonstrate that genes related to cellular
adherence, invasion, migration, proliferation and chemoresistance
are modified upon OCC/MC contact in a cell line specific
manner. Our results suggest that specific pathways may be
targeted to disrupt the acquired pro-metastatic profile.
Materials and Methods
Cell Culture
Ovarian cancer cell lines SKOV3 (HTB-77) and OVCAR3
(HTB-161) were purchased from ATCC and maintained in
culture following ATCC recommendations (DMEM high glucose
[Hyclone, Thermo Scientific], 10% FBS [Hyclone, Thermo
Scientific], 1% Penicillin-Streptomycin-Amphotericyn B solution
[Sigma], 1X Non Essential Amino-Acid [Hyclone, Thermo
Scientific]). The ovarian cancer cell lines were stably transduced
by lentiviral vectors encoding eGFP (Genethon, Evry). Mesen-
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Vancouver, CA) maintained and expanded in culture using
MesenCultH MSC Basal Medium completed with Mesenchymal
Stem Cell Stimulatory Supplements (Stem cell Inc, Vancouver,
CA). Their ability to differentiate in adipocytes, osteoblasts and
chnodrocytes was verified as per the supplier instructions (data not
shown).
Co-Cultures
We established co-cultures of eGFP-OCC with BM-MC at ratio
of 1:2 for 24 hours. OCC were differentiated from BM-MC based
on their eGFP and Ep-Cam. The different cell populations were
sorted using Fluorescence Activated Cell Sorting (FACS).
Fluorescent activated cell sorting
Cells were harvested and blocked in PBS-5%FBS-1%BSA-
10%FcR Blocking Reagent (Myltenyi Biotec). Single-cell suspen-
sion was analyzed and sorted on SORP FACSAria2 (BD
Biosciences). Data were processed with FACSDiva 6.3 (BD
Biosciences). Doublets were excluded by FSC-W 6 FSC-H and
SSC-W 6SSC-H analysis, single stained channels were used for
compensation, and fluorophore minus one (FMO) controls were
used for gating. eGFP fluorescence was acquired with 488 nm blue
laser and 510/50 nm emission, 50 000 events were acquired per
sample. Charts display the median of fluorescence intensity (mfi)
relative to control. During cell-sorting purity-phase mask was
applied. OCC monocultures were processed and sorted as
controls.
Gene expression analysis
Upon cell sorting mRNA was isolated using Trizol reagent
followed by purification using RNAeasy extraction kit from
Qiagen. 200 ng of total RNA were analyzed on Affymetrix
GeneChip Human Genome U133 Plus 2.0 Array. Data were
analyzed using Partek software (St Louis, MO). Class comparison
between different conditions (three biological replicates) was
performed to identify gene expression changes with significant
expression differences and two-fold increased or decreased
expression [14,15,16]. Principal component analysis (PCA) were
performed using Partek with the standard settings. Statistical
comparisons for microarray data were calculated using two-tailed
Students t-test. Benjamini-Hochberg correction was applied to
limit positive false discovery rate to 5%. Statistical comparisons for
categorical data were achieved using Chi-squared test. Correla-
tions were performed using Pearson correlation. All other
statistical comparisons were calculated using two-tailed t-test.
Ingenuity Pathway Analysis
We used Ingenuity Pathway Analysis software (IPA) (Ingenuity
Systems, Redwood City, CA) for network analysis of genes that
were differentially regulated upon co-culture. We defined global
gene lists representing IPA keywords: ‘‘Metastasis’’, ‘‘Proliferation
of cell lines’’ and ‘‘Cell death of tumor cell line’’. All edges are
supported by at least one reference from the literature, textbook,
or canonical information stored in the Ingenuity Pathways
knowledge database. P-values for enrichment of biological
functions were generated based on the hypergeometric distribution
and calculated with the right-tailed Fisher’s exact for 262
contingency tables as implemented in Ingenuity.
Adherence assay
96 well-plates were coated with Matrigel (BD-Biosciences). 20
000 OCC-eGFP were seeded per well and incubated in 5%CO2
incubator at 37uC for 15, 30 and 60 minutes. Non-adherent cells
were washed away. Adherent cells were quantified using
fluorescence plate reader (Wallac, Perkin Elmer) (488 nm excita-
tion, 510 emission). All functional experiments were performed in
biological triplicates.
Migration/Invasion assays
8 mm pores transwell permeable supports were coated with
Matrigel. 50 000 viable OCC (sorted from co- and monoculture)
were seeded per well and incubated in 5%CO2 at 37uC for 12 and
24 hours. OCC migration and invasion was then assessed using a
fluorescence plate reader (Wallac, Perkin Elmer).
Proliferation assay
5000 OCC were seeded in monoculture or on MSC-mOrange
monolayer in a serum free/cytokine free media. OCC were
counted every two days during 14 were coated with Matrigel. 50
000 days under a microscope using GFP fluorescence. Each day
ten fields were quantified.
Chemoresistance
100000 OCC were seeded in monoculture or with BM-MSC in
1:2 ratio. Mono- and co-culture were treated with 90 mM
Cisplatinum and 6 mM Paclitaxel (Sigma) for 24 h. Cells were
then stained with Calcein Red-Orange, LIVE/DEAD Aqua blue
(Invitrogen, Molecular Probes), CD73-APC (Biolegend, clone:
AD2) according to manufacturer’s instructions and analyzed by
FACS. OCC were defined as cells GFP+CD73-, living OCC were
defined as calcein Red-Orange+ LIVE/DEAD aqua-. 50 000
events were acquired per sample.
Statistical analysis
Student-t tests, Fisher exact tests and chi-square tests were
performed as appropriate. All p-values are two-sided with
statistical significance evaluated at the 0.05 alpha levels. Ninety-
five percent confidence intervals (95% CI) were calculated to assess
the precision of the obtained estimates. All statistical analysis was
done using the data analysis plug-in of Microsoft Excel 2008.
Results
Modification of the OCC transcriptome upon interaction
with MC
In order to investigate modifications of OCC transcriptome
upon MC contact, we designed a coculture model in which OCC
are cultivated alone (control condition) or in presence of MC (test
condition) during 24 h in a serum free, cytokine free medium.
OCC (control and test conditions) were then sorted by FACS
based on their co-expression of the epithelial cell adhesion
molecule (EpCAM, CD326) and the enhanced-Green Fluorescent
Protein (eGFP) (Figure 1.A).
Upon MC contact, the transcriptome of the two cell lines we
tested (NIH:OVCAR3-eGFP and SKOV3-eGFP) was dramati-
cally modified (Figure 1.B). NIH:OVCAR3 significantly upregu-
lated 26 genes and downregulated 10 genes (Table S1); SKOV3
significantly upregulated 18 genes and downregulated 3 genes
(Table S2). Changes observed in the two ovarian cancer cell lines
did not allow us to establish a common gene signature upon MC
contact (Figure 1.B, Table S1, Table S2). However using Ingenu-
ity Pathway Analysis software, we were able to identify three
biological function clusters enriched upon contact with MC:
‘‘Metastasis’’ (NIH:OVCAR3, p=6.48*10
26; SKOV3,
p=5.42*10
25), ‘‘Proliferation of cell lines’’ (NIH:OVCAR3,
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27; SKOV3, p=6.79*10
26) and ‘‘Cell death of
tumor cell line’’ (NIH:OVCAR3, p=5.68*10
28; SKOV3,
p=7.62*10
25). These clusters were shared between NIH:OV-
CAR3-eGFP and SKOV3-eGFP (Table 1).
Taken together these data indicate that despite the lack of
overlapping regarding the genes up-or down-regulated by MC
contact, the same biological function clusters were enriched in the
two ovarian cancer cell line we tested. In this article, we set forth
Figure 1. Modification of OCC transcriptome upon interaction with MC. A. Contour plot showing a typical discrimination of OCC and MC by
FACS. OCC were defined as eGFP+EpCAM+ (green population) whereas MCs were defined as eGFP-EpCAM- (dark grey population). B. PCA analysis for
the ovarian cancer cells lines alone or post-contact with the Mesenchymal cells.
doi:10.1371/journal.pone.0038340.g001
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PLoS ONE | www.plosone.org 5 May 2012 | Volume 7 | Issue 5 | e38340the idea that MC exert a pro-metastatic effect on OCC, therefore
we decided to validate the biological function clusters described in
Table 1 with in vitro experimentations.
MCs increase OCC metastasis biological function:
adherence, migration and invasion
Peritoneal metastasis initiation involves adherence, migration,
and invasion through the mesothelium. Using IPA software, we
Figure 2. MCs increase OCC metastasis biological function: adherence, migration and invasion. A. OCC-eGFP (NIH:OVCAR3, left chart
and SKOV3, right chart) were seeded on a Matrigel (BD Biosciences)-coated well for 10 min, 15 min, 30 min and 1 hour. Increased adherence to the
ECM is observed when OCC were preemptively cultivated with MC (light grey bars) compared to the control (dark grey bars). B. Scheme representing
the invasion and migration assay. C. Sorted OCC were seeded on (un) coated transwells and GFP signal of each well under the coated membrane was
acquired after 24 h. Increased migration and invasion through the ECM is observed when OCC were preemptively cultivated with MC (light grey bars)
compared to the control (dark grey bars). SEM are represented, n=3, | p,0.05 t-Student Test.
doi:10.1371/journal.pone.0038340.g002
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PLoS ONE | www.plosone.org 6 May 2012 | Volume 7 | Issue 5 | e38340identified a biological function cluster: ‘‘metastasis’’, which was
enriched upon ovarian cancer cell contact with MC. We therefore
investigated the biological effect corresponding to this genomic
pro-metastatic modification performing in vitro migration, adher-
ence and invasion assays. Upon 24 hours of co-culture with MC,
OCC (EpCAM+ eGFP+) were sorted (Figure 1A). We then tested
OCC ability’ to adhere to ECM. OCC (NIH:OVCAR3 and
SKOV3) were seeded on a Matrigel (BD Biosciences)-coated well
for 10 min, 15 min, 30 min and 1 hour. We defined the
adherence to the ECM as the residual GFP fluorescence we were
able to acquire following PBS washing. As displayed in Figure 2.A,
both ovarian cancer cell line show an increased adherence to the
ECM: 1.38 fold increase relative to the control for NIH:OV-
CAR3-eGFP at 10 min, and 1.94 fold increase at 1 h, 1.28 and
1.85 fold for SKOV3-eGFP at 10 min and 1 hour respectively.
To perform migration assay, we seeded 8 mm transwell with the
OCC sorted upon 24 h of co-culture with MC. We tested their
ability to migrate through the transwell insert and measured the
GFP signal of each well after 24 h. We observed a 2 fold and 2.5
fold increased migration with NIH:OVCAR3 and SKOV3 after
MC contact, respectively.
To perform invasion assay, we used Matrigel (BD Biosciences)-
coated 8 mm transwells. Sorted OCC were seeded on coated
transwells and GFP signal of each well under the coated
membrane was acquired after 24 h. Cell migration was increased
by 2.5 times and 1.5 times for NIH:OVCAR3 and SKOV3 after
MC contact, respectively.
We demonstrated here, that MC through direct interaction with
OCC were able to change drastically OCC behavior. Following
MC contact OCC displayed a greater adherence to the ECM, a
faster migration and a more efficient invasion through the ECM.
Taken all together these observations emphasize the role of MC,
to enhance at both the transcriptional and functional level the
metastatic potential of OCC.
Mesenchymal cells sustain ovarian cancer cells
proliferation
Following mesothelial infiltration, development of peritoneal
carcinosis involves proliferation of ovarian cancer cells within their
surrounding stroma. We clustered genes based on their biological
function, and demonstrated that genes involved in proliferation of
cell lines were enriched upon MC contact with OCC (Table 1).
We therefore investigated the ability of the MC to sustain OCC
proliferation. Since the use of serum in order could greatly hamper
the study of the effect of the microenvironment on the ovarian
cancer cell, we performed the proliferation assay in a in a serum
free, cytokine free context. OCC-eGFP (NIH:OVCAR3 and
SKOV3) were cultured alone or on a MC-mOrange monolayer.
We observed that MC sustained cancer cell growth at least for
15 days while OCC were quiescent in their absence (Figure 3A–
C).
MC induce Chemoresistance of ovarian cancer cells
The treatment of ovarian cancer with peritoneal carcinosis, i.e.
advanced stage disease, includes chemotherapy before or after
surgery. We clustered genes based on their biological function, and
demonstrated that genes involved in ‘‘Cell death of tumor cell
Figure 3. MC sustains OCC proliferation in a serum free cytokine free context. A. OCC were cultivated on a MC expressing mOrange or
direclty on the plastic dish. Proliferation assay was carried out in a serum free-cytokine free media. Pictures were taken every two days, and GFP cells
were quantified. B. Detail of the well on day 14, we can notice OCC display a normal morphology. C. Chart displaying cell count carried over 14 days.
OVCAR3 eGFP when seeded on a MC are able to sustain cell cycle in a serum free cytokine free media. Similar results were obtained with SKOV3 (data
not shown). SEM are represented, n=3, | p,0.05 t-Student Test.
doi:10.1371/journal.pone.0038340.g003
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PLoS ONE | www.plosone.org 7 May 2012 | Volume 7 | Issue 5 | e38340line’’ of cell lines were enriched upon MC contact with OCC
(Table 1). We therefore investigated whether MC are capable of
promoting OCC resistance to chemotherapy.
OCC were cultivated for 24 h in absence or presence of MC in
a serum free, cytokine free media. The mono- or cocultures were
then treated for 24 hours with 90 mM Cisplatinum and 6nm
Paclitaxel. Prior FACS analysis, cells were stained with a viability
dye (Calcein) and a cell death dye (LIVE/DEAD). OCC and MSC
were discriminated on their differential expression of CD73 and
eGFP, OCC were defined as eGFP+CD73- (figure 4.A, upper
panel). Viable OCC after chemotherapy treatment was defined as
Calcein High/Live Dead (LD) negative (figure 4.A, lower panel).
Figure 4. MC protects OCC from chemotherapy induced cell death. A. Explanative scheme of FACS analysis. B. OCC or OCC co-cultivated with
MSC were treated for 48 hours with 90 mM of Cisplatin and 6 nm of Paclitaxel. Cell types were discriminated by FACS using GFP as a cancer cell
marker, and CD73 as an MC marker. Cell death analysis was carried out using the dual Calcein/Live Dead staining. C. Quantitation of cell death analysis
experiments. OCC display a resistance to conventional chemotherapy treatment when co-cultivated with MC compared to the control. SEM are
represented, n=3, | p,0.05 t-Student Test.
doi:10.1371/journal.pone.0038340.g004
Mesenchymal Niche Modifies Ovarian Cancer Biology
PLoS ONE | www.plosone.org 8 May 2012 | Volume 7 | Issue 5 | e38340Co-culture of OCC with MC did not modify cell viability or
mortality before chemotherapy (Figure 4.B and 4.C). Chemother-
apeutic treatment resulted in 61.4% (NIH:OVCAR3) and 63.4%
(SKOV3) of OCC death (Calcein low, LD high cells) (Figure 4.C).
While OCC death was reduced after chemotherapy with 42.3%
(NIH:OVCAR3) and 42% (SKOV3) of Calcein low, LD high cells
in presence of MC (Figure 4.C).
In corroboration with our IPA results, we demonstrated that
MC were not only able to enrich gene clusters that are involved in
regulation of cell death, but were also promoting OCC resistance
(1.45 and 1.50 fold decrease in cell death for NIH:OVCAR3 and
SKOV3 respectively) to chemotherapy.
Discussion
Our study demonstrated that MCs modify OCC transcriptome
toward a metastatic profile. Upon contact with MC, OCC lines
(NIH:OVCAR3 and SKOV3) enriched three biological function
clusters: ‘‘Metastasis’’, ‘‘Proliferation of cell lines’’, ‘‘Cell death of
tumor cell line’’. We validated that these functions were modified
in vitro. Our data indicated that MC contact with OCC increased
adherence, migration and invasion to/through the ECM, prolif-
eration, and resistance to chemotherapy. This is consistent with
reports of MCs modifying ovarian cancer cells behavior
[7,8,11,12,17].
The peritoneal cavity is lined by a continuous single layer of
mesothelial cells [18]. Mesothelial cells are described in the
literature as the first line of defense against all abdominally
metastasizing tumors. Therefore, the development of peritoneal
carcinosis in ovarian cancer involves several key steps: adhesion
and clearance to/of the mesothelial layer, migration and invasion
through the mesothelial and sub-mesothelial layers, and prolifer-
ation of the ovarian cancer cells [2,19]. While mesothelial cells
have been described to inhibit ovarian cancer cell adhesion and
invasion [20], carcinoma-associated fibroblasts (CAF) display the
opposite effects [12,20]. In our study, we demonstrated that
mesenchymal cells (MC) increased ovarian cancer cells adhesion
and invasion. This is in line with Kenny and al data where they
described mesenchymal cells-derived fibroblasts promote ovarian
cancer cell migration and invasion in a MMP2 dependant manner
[21]. Recently, they also showed the role of adipocytes in ovarian
cancer progression [22]. Noteworthy, MC are described to
differentiate into CAF and adipocytes when they are exposed to
ovarian cancer cell supernatant [11,17]. Taken together these data
demonstrate that the mesenchymal lineage (MC, CAF, adipocytes)
constitutes a permissive niche to ovarian cancer cells, and could
explain the peritoneal tropism of ovarian tumor metastatic
outgrowth.
In this study we demonstrated that MC sustain ovarian cancer
cell proliferation in a serum free, cytokine free context. These data
obtained in vitro, are in corroboration with several in vivo report.
For instance, Pasquet and al. demonstrated that mesenchymal
ascites derived stromal cells promote ovarian tumor growth in
nude mice [9]. This ability of mesenchymal ascites derived stromal
cells to promote ovarian tumor growth was explained by the
induction of ovarian cancer cell proliferation, and by an increase
of angiogenesis [9]. More recently, Mac Lean and al. showed that
MC could also increase ovarian tumor heterogeneity. Altered
secretion of BMP2 by MCs is able to increase the number of
ovarian cancer stem cells and consequently stimulate ovarian
tumor growth in an immuno-compromised mouse [12]. Another
component of mesenchymal lineage, the adipocytes, was also
reported to increase in vitro and in vivo tumor growth by
providing energy to the cancer cells through the production of
fatty acids [22]. The role of the fatty acid on the ovarian cancer
cell biology is recently emerging. A recent work showed that
chemoresistance were induced by MC through the release of
platinium-induced fatty acids [23]. These fatty acid demonstrated
the ability, in a context of xenograft, to protect OCC from
numerous chemotherapeutic agents [23]. Since the main clinical
issue regarding the ovarian disease is the relapse emerging from a
platinum resistant minimal disease, it is interesting to note that
MC and other mesenchymal components are able to drive both
proliferation and resistance to therapy by providing a permissive
‘‘metabolic’’ niche.
Therefore MC and MC-derived cells determine both ovarian
cancer biology and ovarian cancer response to therapy. Under-
standing gene expression changes that occur in OCC upon their
interaction with their MC niche could help to define new
therapeutic approaches. Our aim in this study was to describe a
relationship between changes that occur in ovarian cancer cell line
at the transcriptomic level and differences in cell behavior we
observed with the coculture assay we performed. One limitation of
this study is that compared transcriptomic analysis of NIH:OV-
CAR3 and SKOV3 in contact with MC failed to define a shared
global change at the gene expression level. Recently the cancer
genome atlas published their work on ovarian serous adenocar-
cinomas [24]. They were able to define four new subsets
(differentiated, immunoreactive, mesenchymal and proliferative)
of ovarian high-grade serous adenocarcinomas based on a gene
expression study of 489 patients [24]. One explanation for the lack
of overlap in gene expression changes between NIH:OVCAR3
and SKOV3 could be that each cell line belongs to different subset
of ovarian high-grade serous adenocarcinomas. Indeed OVCAR3
and SKOV3 could represent different cell types based on the
principal component analysis (Figure 1.B). Despite the apparent
discrepancy, we were able to define three identical biological-
function gene clusters enriched upon MC contact that corrobo-
rated our in vitro data. Surprisingly, the mesenchymal niche seems
to be permissive to two different subsets of ovarian serous
adenocarcinomas adhesion, migration, invasion, proliferation
and chemoresistance. Further studies on the effect of the
microenvironment on each different subset of ovarian serous
adenocarcinomas (differentiated, immunoreactive, mesenchymal
and proliferative) are therefore required to refine the genes
involved and define innovative therapeutic approaches.
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